Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the page. Removed the previous Revision: v3.4.1 text and the government funding operating-status notice.
    Difference
    0.5%
    Check dated 2026-02-11T00:33:23.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A government funding lapse notice was added at the top of the page, informing users that information may not be up to date and directing to cc.nih.gov and opm.gov. The site revision version now shows v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T00:23:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Glossary toggle added (Show glossary) and study record metadata updated to Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; legacy labels and prior revision (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) were removed.
    Difference
    0.2%
    Check dated 2026-01-27T23:21:50.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-13T17:56:11.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Footer changes: the HHS Vulnerability Disclosure link was removed and the Revision: v3.3.3 tag was added. These changes are limited to footer and metadata and do not affect the study content.
    Difference
    0.1%
    Check dated 2025-12-23T07:47:29.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is shown, replacing the previous v3.3.1. This appears to be a minor frontend update that does not alter study details or functionality.
    Difference
    0.1%
    Check dated 2025-12-01T16:39:17.000Z thumbnail image

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.